patent/MX-350761-B

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-350761-B

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
filingDate	2010-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd31ac726f0522a72df92facd92bb6eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4aa66accbe337e7955c3a9a41041d74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09978e0f0f71a87ed179af59d64c784d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c91835202745d40c675d9198506a64f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f669901caa85757d29f44054de4f534b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f452496cf8ff509542631bb7c6c1382c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc9a09511ef8df5608b1b71192103fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_805b36a9590000cee4161bd65771b317 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_704098775718dbcbab56925e20620f83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f3251ebf0e27425aae8254741641203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25ce556c59fd9046e8a99b6452122732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_542da02931615e041c6580fac025739b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfa090a01cb39aea5b29364f77b61904 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db273e6a6172812ded93755b84ce116f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9019c265125a5cb1279d71bf5eca1ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1712d1df8afe6b154d4e4f3c5e86f0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5b62a80807da3bc709db6e59bb698a
publicationDate	2017-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MX-350761-B
titleOfInvention	3-CINASA PHOSFATIDYLINOSITOL ISOINDOLINONE INHIBITORS.
abstract	The present invention relates to compounds useful as inhibitors of PI3K, particularly PI3Ky. The invention also provides pharmaceutically acceptable compositions comprising the compounds and methods for using the compositions in the treatment of various diseases, conditions or disorders.
priorityDate	2009-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866614 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10199

Total number of triples: 61.